Pricing Log in Create free account

BioStem Technologies, Inc. (BSEM) vs Cocrystal Pharma, Inc. (COCP)

BioStem Technologies, Inc. and Cocrystal Pharma, Inc. are both Biotechnology companies. BioStem Technologies, Inc. and Cocrystal Pharma, Inc. are of similar size ($19.4M and $19.3M). Cocrystal Pharma, Inc. grew revenue faster over the last twelve months: −30.4% against −87.1%. BioStem Technologies, Inc. has the higher net margin (−76.0% vs −747.8%) and the higher return on invested capital (55.3% vs 0.00%). Across the 16 metrics below, BioStem Technologies, Inc. leads on 12 and Cocrystal Pharma, Inc. on 4.

Valuation

Metric BSEM COCP Biotechnology median
P/E n/m n/m 10.60
P/S 0.56 10.69 9.40
P/B 0.70 13.60 2.13
Price to free cash flow n/m n/m 25.18
EV/EBITDA 0.68 n/m 0.66
EV/Sales 0.36 9.00 9.02
Earnings yield (137.92%) (73.79%) (32.88%)
Free cash flow yield 0.00% (56.09%) (23.13%)

Profitability

Metric BSEM COCP Biotechnology median
Gross margin 91.16% 9.10% 68.51%
Operating margin 52.87% (760.72%) 0.00%
Net margin (76.02%) (747.78%) 0.00%
Free cash flow margin 0.00% (598.50%) 0.00%
Return on equity 0.00% (311.68%) (51.96%)
Return on assets 0.00% (151.10%) (46.06%)
Return on invested capital 55.34% 0.00% 0.00%

Growth

Metric BSEM COCP Biotechnology median
Revenue growth (TTM) (87.14%) (30.38%) 6.76%
EPS growth (last fiscal year) (126.53%) 54.65% 29.88%
Revenue growth, 5-year CAGR — (33.30%) 9.75%
Net income growth, 5-year CAGR — 0.00% 0.00%

Health

Metric BSEM COCP Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 0.98 1.24 4.97
Net debt to EBITDA 0.00 0.82 1.01

Dividend

Metric BSEM COCP Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric BSEM COCP Biotechnology median
Market cap 19.42m 19.27m 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack